Funded by the US Food and Drug Administration (HHSF223201810209C).
In 2016, there were over 40,000 deaths from opioid overdose, a five-fold increase since 1999. Prescriptions for acute pain are a driving factor in introducing patients to opioids and creating potential sources of pill diversion to others. Of those who started abusing heroin after 2010, 66% did so after first abusing prescription opioids. A key knowledge gap inhibiting progress to reduce excessive opioid prescribing centers around the paucity of acute painful indication-specific clinical data to guide practitioners in safe and effective dosing, duration, and quantity of opioid medications. Current practice is neither patient-specific nor procedure-specific. With funding from the US Food and Drug Administration (HHSF223201810209C), we are building upon our previously successful efforts using patient telephone calls to collect data on patient-reported outcomes and opioid usage after an opioid is prescribed for acute pain to develop and evaluate strategies to collect this patient-centered data in an effective, scalable fashion
Back to Research